ORIC Pharmaceuticals Inc. operates as a biopharmaceutical company. Founded by Charles Sawyers and Scott Lowe in 2014, ORIC Pharmaceuticals is backed by investors that include Fidelity Management and Research Company, Invus, Kohlberg Kravis Roberts, Memorial Sloan – Kettering Cancer Center, and OrbiMed and is headquartered in South San Francisco.